Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation

Launched by ELSAN · Feb 21, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how to manage young children, specifically those aged 2 months to 2 years, who have a condition called moderate acute bronchiolitis, which is a common respiratory illness. The focus is on whether these children can safely receive care at home instead of being hospitalized. The study aims to understand if children in this situation need oxygen therapy while being treated at home. Each year, many infants experience bronchiolitis, and while it can be concerning for parents, moderate cases can often be managed safely outside of a hospital setting when the child is stable and not showing severe symptoms.

To qualify for this study, children must have moderate bronchiolitis for at least 48 hours, have oxygen levels above 92%, and this should be their first episode of the illness. Parents will need to agree to home treatment, and the child must not have other serious health issues that could complicate their care. Participants will be closely monitored by pediatric teams, ensuring they receive proper care and support during their home hospitalization. This trial could help improve how bronchiolitis is managed in young children, making the experience less stressful for families.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any infant with moderate bronchiolitis according to the HAS definition (except for the SpO2 criterion which must be greater than or equal to 92% to avoid the patient being on oxygen therapy upon admission)
• • Age \> 2 months and ≤ 2 years
• • Respiratory syndrome for 48 hours
• • Infant with a first episode of bronchiolitis
• • Referral of the general practitioner/treating pediatrician for home hospitalisation care
• • Parents' agreement for the choice of home hospitalisation care
• • Non-opposition or free and informed consent of both parents to the use of the child's health data
• Exclusion Criteria:
• • Patient not receiving health protection
• • Comorbidities: congenital heart disease with shunt, chronic pulmonary pathology including bronchopulmonary dysplasia, neuromuscular pathology, immune deficiency, multiple disabilities Congenital heart disease
• • Refusal of one or both parents for the proposed pathway
• • Doubts about the parents' understanding of the nature of home hospitalisation care
• • Severe bronchiolitis or with saturation \< 92%
• • Moderate bronchiolitis but evolving for less than 48 hours
• • Cases of psychiatric pathologies or depressive syndrome diagnosed in the parents.